FindTrial
Sign In

The effect of blood serum eosinophilic granulocyte count on rehabilitation therapy in COPD

The effect of blood serum eosinophilic granulocyte count on rehabilitation therapy in COPD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035245
Enrollment
Unknown
Registered
2020-08-05
Start date
2019-09-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Control group+EOS<2%:Routine medicine treatment
Rehabilitation group+EOS=2%:Routine medicine treatment + 8-weeks comprehensive lung rehabilitation therapy
Rehabilitation group+EOS=2%:Routine medicine treatment

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >=40 years old; 2. (FEV1 / FVC) < 70% after inhalation of bronchodilator; 3. Have not participated in the lung rehabilitation program in the past three months.

Exclusion criteria

Exclusion criteria: 1. Severe arrhythmia, heart failure, recent unstable angina attack or acute myocardial infarction; 2. Patients with severe bone and joint diseases affect their daily life; 3. Neuromuscular diseases lead to dyskinesia; 4. Severe cognitive impairment and abnormal mental behavior; 5. Peripheral vascular disease.

Design outcomes

Primary

MeasureTime frame
6-minute walk distance;—

Secondary

MeasureTime frame
CAT;MMRC;Borg scale;ADL;Hamilton Anxiety Scale;Hamilton Depression Scale;—

Countries

China

Contacts

Public ContactYajuan Chen

The First Affiliated Hospital of Chongqing Medical University

1457743228@qq.com+86 15111926661

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026